Innovent Biologics

Innovent Biologics is a company listed under the stock ticker HKEX (HK).

View the org chart displaying its 17 main executives

Samuel Zhang has joined the company as Global Chief Business Officer (posted on April 30 2024).
Nageatte Ibrahim has joined the company as Chief Medical Officer, Oncology (posted on April 17 2024).

Create your alert
to follow the executive moves at Innovent Biologics.

Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
Histogen has filed for bankruptcy protection (posted on April 19 2024).

Contact by email its executives including Michael Yu Premium

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Executive Data Sets

Executives

Companies

The Official Board